Skip to main content
SpringerLink
Log in

In situ end labeling and its applications to the study of endocrine disease: How can we study programmed cell death in surgical pathology materials?

  • Editorial
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wyllie AH. Cell death: a new classification separating apoptosis from necrosis. In: Bowen ID, Lockshin RA, eds. Cell death in biology and pathology. London: Chapman and Hall, 1981; 9–34.

    Google Scholar 

  2. Umansky SR. The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, aging. J Theor Biol 97: 591–602, 1982.

    Article  PubMed  CAS  Google Scholar 

  3. Kerr JFR, Searle J, Harmon BV, Bishop CJ. Apoptosis in perspectives on mammalian cell death. In: Potten CS, ed. Oxford: Oxford University Press, 1987; 93–98.

    Google Scholar 

  4. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170: 1–8, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Hall PA, Levinson DA. Assessment of cellular proliferation in histological material. J Clin Pathol 43: 184–192, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Hiraishi K, Suzuki K, Hakomori S, Adachi M. LeY antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 3:381–390, 1993.

    Article  PubMed  CAS  Google Scholar 

  8. Sasano H, Imatani A, Shizawa S, Suzuki T, Nagura H. Cell proliferation and apoptosis in normal and pathologic human adrenal. Mod Pathol 8:11–17, 1995.

    PubMed  CAS  Google Scholar 

  9. Dremier B, Goldstein J, Mosselmans R, Dumont JE, Geland P, Robaye B. Apoptosis in thyroid cells. Biochem Biophys Res Commun 200:52–58, 1994.

    Article  PubMed  CAS  Google Scholar 

  10. Drewett N, Jacobi JM, Willgoss DA, Lloyd HM. Apoptosis in the anterior pituitary gland of the rat: studies with estrogen and bromocriptine. Neuroendocrinology 57:89–95, 1993.

    PubMed  CAS  Google Scholar 

  11. Yin D, Kondo S, Takeuchi J, Morinaga T. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine. Oncol Res 5: 383–387, 1993.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Tohoku University School of Medicine, 2-1 Seiryou machi, Aoba-ku, 980, Sendai, Japan

    Hironobu Sasano MD

Authors
  1. Hironobu Sasano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sasano, H. In situ end labeling and its applications to the study of endocrine disease: How can we study programmed cell death in surgical pathology materials?. Endocr Pathol 6, 87–89 (1995). https://doi.org/10.1007/BF02739871

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739871

Search

Navigation